CHELMSFORD, Mass. — ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, recently announced that it will display its fully-integrated portfolio of resuscitation devices and data management solutions that address each link in the Chain of Survival in Booth #303 at ECCU 2010 (Emergency Cardiovascular Care Update) December 8-10 in the Douglas Pavilion of the Manchester Grand Hyatt Hotel in San Diego. ZOLL’s technology is strongly aligned with the emphasis in the 2010 Guidelines on high-quality CPR and minimizing interruptions in chest compressions.
In addition to the exhibit, ZOLL is sponsoring nine of the 50 sudden cardiac arrest (SCA) survivors, who were saved with the help of bystander CPR and ZOLL devices, participating in a 50th celebration of CPR. Honored will be Drs. James Jude, Guy Knickerbocker and the late William Kouwenhoven*. The ZOLL survivors, aged 8 to 64, will be coming from all parts of the country to celebrate the chest compression technique these three physicians pioneered in l960 that helped save their life. ZOLL will have copies of the original landmark article, entitled “Closed-Chest Cardiac Massage” written by the doctors and published in the Journals of American Medical Association on July 9, 1960, to hand out while supplies last.
2010 Guidelines Focus: High Quality CPR and Minimizing CPR Interruptions
The increased focus in the new Guidelines on methods to ensure high-quality CPR has been an ongoing commitment of ZOLL since 2002 when it was the first to introduce real-time CPR feedback in its AED Plus. Today, all ZOLL defibrillators, from ACLS to AEDs, feature Real CPR Help audio and visual feedback for the correct rate, depth, release*, and tracking of idle time.
Further supporting the 2010 Guidelines are the R Series Code-Ready family of defibrillators for hospitals, the E Series defibrillators for EMS, and the AED Pro, which all offer See-Thru CPR, a breakthrough technology that filters out CPR artifact from the ECG to reduce CPR interruptions. Use of low energy biphasic continuous waveform capnography in the R Series and the E Series also determines tube placement, tracks resuscitation progress, and provides a clear indication of ROSC.
The E Series, when paired with the RescueNet STEMI Management Solution**, becomes an advanced and versatile system that can help health care providers speed up the treatment of patients with ST elevation Myocardial Infarction, as recommended in the 2010 Guidelines. It allows EMS providers to easily acquire and transmit ECG information from the field into the cath lab to assist clinicians in meeting standards for door-to-balloon times.
The AutoPulse Non-invasive Cardiac Support Pump is classified as a Class IIb device in the new Guidelines and provides an easy-to-use, load-distributing LifeBand that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest (SCA). The AutoPulse delivers high-quality, uninterrupted CPR chest compressions to maintain myocardial and cerebral perfusion even when moving patients, traveling in an ambulance or while undergoing PCI.
Additional products that support implementation of the recommendations include:
“¢ For early intervention, the LifeVest Wearable Defibrillator is worn by patients at risk for SCA, providing protection during their changing condition and while permanent SCA risk has not been established. The LifeVest allows a patient’s physician time to assess his/her long-term arrhythmic risk and make appropriate plans.
“¢ For assessing performance to improve care, CodeNet is the first software system that allows hospital teams to better document, manage, and review cardiac arrest event and resuscitation information. CodeNet brings new improvements and efficiencies in data capture, event time synchronization, and case and aggregate reporting.
“¢ The first training app to provide CPR training and practice using the just-released 2010 American Heart Association CPR Guidelines is the new version of PocketCPR for the iPhone**. The application provides clear visual and audio step-by-step coaching on CPR performance and includes the initial steps to follow in the Chain of Survival.
“¢ ZOLL Intravascular Temperature Management (IVTM) offers health care providers the power and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients.
Conference Presentations Highlight ZOLL Resuscitation Technology
Four conference sessions will address the benefits of ZOLL technology in advancing cardiac care. These include:
Thurs., Dec. 9
“¢ “High Quality Pre Hospital Resuscitation: Making the Leap from Concept to “˜Real Life'”, Bentley Bobrow, M.D. 3:45-4:30 pm
Fri., Dec 10
“¢ “Quality Improvement for Resuscitation in Hospital Settings,” Daniel Davis, M.D. 11:15 a.m. — noon
“¢ “The Renaissance of Cardiac Resuscitation,” Tia Valentine, RN., CEN, MSN, 2:45 — 3:30 p.m.
“¢ “Using Electronic Codes to Improve Outcomes,” Melissa Hutchinson, MN, RN, CCNS, CCRN-CMC, CWCN. 3:34 — 4:30 p.m.
About ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit www.zoll.com.
* Dr. Kouwenhoven to be represented posthumously by his grandson, Nicholas Kouwenhoven.
**Requires FDA 510 (k) and Health Canada Medical Device License clearance and is not yet available for sale in the U.S. or Canada.
